4.6 Review

Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions

Related references

Note: Only part of the references are listed.
Article Biology

Aβ initiates brain hypometabolism, network dysfunction and behavioral abnormalities via NOX2-induced oxidative stress in mice

Anton Malkov et al.

Summary: The activation of NADPH oxidase 2 (NOX2) is identified as the primary mechanism behind A beta(1-42)-related glucose hypometabolism and network dysfunction. Inhibiting NOX2 may prevent the pathological changes associated with AD-related brain glucose hypometabolism.

COMMUNICATIONS BIOLOGY (2021)

Article Biochemistry & Molecular Biology

SIRT5 Represses Neurotrophic Pathways and Aβ Production in Alzheimer's Disease by Targeting Autophagy

Shanshan Wu et al.

Summary: The study revealed that SIRT5 plays a crucial role in the treatment of Alzheimer's disease (AD), as its overexpression can ameliorate AD progression by activating autophagy, reducing oxidative stress, and protecting neurons by inhibiting activated microglia and astrocytes. This therapeutic approach shows promise for AD treatment.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Familial Alzheimer's disease mutations in amyloid protein precursor alter proteolysis by γ-secretase to increase amyloid β-peptides of ≥45 residues

Sujan Devkota et al.

Summary: Systematic and quantitative analyses were conducted to study the effects of 14 FAD mutations on γ-secretase processing of APP substrates. All mutations resulted in inefficient processing of Aβ peptides longer than 45 residues. Certain mutations provided insights into the mechanism of processive proteolysis.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Clinical Neurology

Aβ (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts

A. Kapasi et al.

Summary: This study found that in individuals with higher Aβ and tau burden, the association between small vessel pathologies and cortical microinfarcts was stronger, suggesting a potential link between neurodegenerative and vascular mechanisms.

STROKE (2021)

Article Clinical Neurology

Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer's amyloidosis

Panchanan Maiti et al.

Summary: The study demonstrates that SLCP exerts neuroprotective properties in 5xFAD mice by decreasing amyloid plaque burden, preventing neuronal death, and preserving dendritic spine density and synaptic markers.

ALZHEIMERS RESEARCH & THERAPY (2021)

Review Psychiatry

Brain Functional and Structural Changes in Alzheimer's Disease With Sleep Disorders: A Systematic Review

Yong-shou Liu et al.

Summary: This systematic review summarizes the brain functional and structural changes in patients with both Alzheimer's disease and sleep disorders. Findings are inconsistent and might be influenced by different imaging techniques, measurements of sleep disorders, and subtypes of the diseases.

FRONTIERS IN PSYCHIATRY (2021)

Article Clinical Neurology

Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Trans-port Across the Blood-Brain Barrier in Alzheimer's Disease

Rui Zhou et al.

Summary: The study revealed that high cholesterol exacerbates cognitive impairment in AD mice by affecting A beta transport through decreasing LRP1 expression and increasing RAGE expression in cerebral microvascular endothelial cells, leading to increased brain apoptosis and worsened cognitive function.

CURRENT ALZHEIMER RESEARCH (2021)

Review Neurosciences

Don't Phos Over Tau: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies

Yuxing Xia et al.

Summary: Phosphorylation is a common post-translational modification in tau protein isolated from Alzheimer's disease patients, with therapeutic approaches targeting phosphorylated tau showing promise in slowing hyperphosphorylation and aggregation. The identification and monitoring of phosphorylated tau could serve as disease-specific biomarkers, aiding in clinical diagnosis and progression monitoring.

MOLECULAR NEURODEGENERATION (2021)

Article Neurosciences

The effects of Danggui-Shaoyao-San on neuronal degeneration and amyloidosis in mouse and its molecular mechanism for the treatment of Alzheimer's disease

Cong Yang et al.

Summary: Danggui-Shaoyao-San may ameliorate Alzheimer's disease by reducing amyloid-beta deposition and improving neuronal degeneration.

JOURNAL OF INTEGRATIVE NEUROSCIENCE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease

Amir Fazlollahi et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)

Article Biochemistry & Molecular Biology

Aβ monomer induces phosphorylation of Tau at Ser-214 through β2AR-PKA-JNK signaling pathway

Hao Wu et al.

FASEB JOURNAL (2020)

Article Clinical Neurology

Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage

Krystal Sotolongo et al.

ALZHEIMERS RESEARCH & THERAPY (2020)

Article Cell Biology

Berberine attenuates Aβ-induced neuronal damage through regulating miR-188/NOS1 in Alzheimer's disease

Manman Chen et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Environmental toxins and Alzheimer's disease progression

Maryam Vasefi et al.

NEUROCHEMISTRY INTERNATIONAL (2020)

Article Clinical Neurology

Early Aβ reduction prevents progression of cerebral amyloid angiopathy

Juliane Schelle et al.

ANNALS OF NEUROLOGY (2019)

Review Biochemistry & Molecular Biology

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

Justin M. Long et al.

Review Medicine, General & Internal

Diagnosis and Management of Dementia: Review

Zoe Arvanitakis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Neurosciences

The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer's Disease

Heinz Hillen

FRONTIERS IN NEUROSCIENCE (2019)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Review Neurosciences

State of Play in Alzheimer's Disease Genetics

Jin-Bao Zhu et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Clinical Neurology

2016 Alzheimer's disease facts and figures

Alzheimers & Dementia (2016)

Review Medicine, Research & Experimental

The amyloid hypothesis of Alzheimer's disease at 25years

Dennis J. Selkoe et al.

EMBO MOLECULAR MEDICINE (2016)

Article Clinical Neurology

Oligomeropathies and Pathogenesis of Alzheimer and Parkinson's Diseases

Gianluigi Forloni et al.

MOVEMENT DISORDERS (2016)

Article Geriatrics & Gerontology

Mislocalization of neuronal tau in the absence of tangle pathology in phosphomutant tau knockin mice

Jonathan Gilley et al.

NEUROBIOLOGY OF AGING (2016)

Article

Twenty-five years of the amyloid hypothesis of alzheimer disease: advances, failures and new perspectives

O. S. Levin et al.

Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova (2016)

Article Neurosciences

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy

Jose Marco-Contelles et al.

FRONTIERS IN NEUROSCIENCE (2016)

Article Pharmacology & Pharmacy

Dangerous Liaisons between Beta-Amyloid and Cholinergic Neurotransmission

Stefano Govoni et al.

CURRENT PHARMACEUTICAL DESIGN (2014)

Article Geriatrics & Gerontology

Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year

J. Winchester et al.

ARCHIVES OF GERONTOLOGY AND GERIATRICS (2013)

Review Integrative & Complementary Medicine

Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (A beta), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy

Anchalee Prasansuklab et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)

Review Biochemistry & Molecular Biology

The amyloid precursor protein: A biochemical enigma in brain development, function and disease

Natalia N. Nalivaeva et al.

FEBS LETTERS (2013)

Review Neurosciences

Exercise counteracts declining hippocampal function in aging and Alzheimer's disease

Karlie A. Intlekofer et al.

NEUROBIOLOGY OF DISEASE (2013)

Review Biochemistry & Molecular Biology

Synaptic Mitochondrial Pathology in Alzheimer's Disease

Heng Du et al.

ANTIOXIDANTS & REDOX SIGNALING (2012)

Review Neurosciences

Amyloid Precursor Protein Processing and Alzheimer's Disease

Richard J. O'Brien et al.

ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)

Review Biochemistry & Molecular Biology

Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease

D. Allan Butterfield et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)

Article Biochemistry & Molecular Biology

β-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure

Jorge Parodi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

Synaptotoxicity of Alzheimer Beta Amyloid Can Be Explained by Its Membrane Perforating Property

Fernando J. Sepulveda et al.

PLOS ONE (2010)

Review Geriatrics & Gerontology

Current Concepts in Alzheimer's Disease: A Multidisciplinary Review

Ludovico Minati et al.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2009)

Article Cell Biology

Autophogy protects neuron from Aβ-induced cytotoxicity

Shih-Ya Hung et al.

AUTOPHAGY (2009)

Review Biochemistry & Molecular Biology

Amyloid Precursor Protein Trafficking, Processing, and Function

Gopal Thinakaran et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Ganesh M. Shankar et al.

NATURE MEDICINE (2008)

Review Cell Biology

Autophagy, amyloidogenesis and Alzheimer disease

Ralph A. Nixon

JOURNAL OF CELL SCIENCE (2007)

Article Biochemistry & Molecular Biology

A primer of amyloid nomenclature

Per Westermark et al.

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2007)

Article Biochemistry & Molecular Biology

Clearance of amyloid-β by circulating lipoprotein receptors

Abhay Sagare et al.

NATURE MEDICINE (2007)

Article Clinical Neurology

Forecasting the global burden of Alzheimer's disease

Ron Brookmeyer et al.

ALZHEIMERS & DEMENTIA (2007)

Article Clinical Neurology

RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease

John E. Donahue et al.

ACTA NEUROPATHOLOGICA (2006)

Review Medicine, General & Internal

Alzheimer's disease

Kaj Blennow et al.

LANCET (2006)

Review Biochemistry & Molecular Biology

Oxidative stress and neurodegeneration: where are we now?

Barry Halliwell

JOURNAL OF NEUROCHEMISTRY (2006)

Review Medicine, General & Internal

Molecular mechanisms of amyloidosis

G Merlini et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Biochemistry & Molecular Biology

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

R Deane et al.

NATURE MEDICINE (2003)

Article Biochemistry & Molecular Biology

β-amyloid peptide activates α7 nicotinic acetylcholine receptors expressed in Xenopus oocytes

KT Dineley et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Review Neurosciences

Clearing the brain's amyloid cobwebs

DJ Selkoe

NEURON (2001)